GlassScriptPhysician profile
Amit N Amin
NPI 1144458027
$81,817.79
in general payments reported to CMS, 2019-2025
60 companies · $8,021 in 2025
The $8,021 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,775 · 2020: $8,143 · 2021: $21K · 2022: $10K · 2023: $22K · 2024: $4,157 · 2025: $8,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,800 · Travel and Lodging: $2,943 · Honoraria: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,950.00 |
| Food and Beverage | $11,679.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,800.00 |
| Travel and Lodging | $2,943.21 |
| Honoraria | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $30,335.46 | 2019-2025 | Venclose Maven Catheter, Rotarexs 6 F X 135 Cm, Venovo |
| Terumo Medical Corporation | $11,702.23 | 2019-2025 | Glidesheath Slender, R2p Misago, Azur Cx Detachable |
| Penumbra, INC. | $10,016.12 | 2020-2025 | Indigo System |
| Boston Scientific Corporation | $7,114.00 | 2019-2025 | Varithena Administration Pack, Ranger, Eluvia |
| Philips North America LLC | $6,371.33 | 2019-2025 | (6554) Periph Vasc Undiv, Other Rental, IV Other |
| Abiomed | $4,637.53 | 2019-2025 | Impella |
| Abbott Laboratories | $1,746.69 | 2019-2025 | Diamondback Coronary, Esprit, Perclose Proglide |
| Shockwave Medical, INC | $1,122.48 | 2019-2025 | Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $1,121.54 | 2023-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Alphavac |
| Infraredx, INC. | $1,000.00 | 2025 | |
| Cardiovascular Systems INC. | $922.88 | 2019-2023 | Diamondback Peripheral |
| Cook Medical LLC | $610.61 | 2019-2022 | |
| Endologix LLC | $597.67 | 2024-2025 | Torus Stent Graft System, Endocross Device |
| Janssen Pharmaceuticals, INC | $385.84 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $381.09 | 2019-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veryan Medical Incorporated | $306.08 | 2021 | |
| Medtronic Vascular, INC. | $300.56 | 2019-2020 | |
| Imperative Care, INC | $281.97 | 2025 | Symphony Catheter, Prodigy Catheter |
| E.R. Squibb & Sons, L.L.C. | $270.77 | 2023-2025 | Camzyos, Eliquis |
| Surmodics, INC. | $207.96 | 2022-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight, Sublime Microcatheter, 014, 65cm, Angle |
| Asahi Intecc USA, INC. | $203.99 | 2022-2024 | Peripheral Vascular |
| Novo Nordisk INC | $162.18 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $150.10 | 2021-2025 | Symplicity G3, Onyx Frontier, Ffrangio |
| Inquis Medical, INC. | $142.28 | 2025 | Aventus |
| Avantec Vascular Corporation | $125.00 | 2025 | |
| Inari Medical, INC. | $122.97 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ge Healthcare | $119.79 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.53 | 2021-2025 | Lifevest |
| Cordis US Corp. | $117.39 | 2022-2023 | Saber |
| Astrazeneca Pharmaceuticals LP | $116.26 | 2020 | |
| Pfizer INC. | $96.97 | 2019-2024 | |
| Arbor Pharmaceuticals, INC. | $91.10 | 2019 | |
| Vasorum USA INC. | $88.66 | 2022 | |
| Atricure, INC. | $84.71 | 2023-2025 | Synergy Ablation System |
| Cardiva Medical, INC. | $68.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $36.78 | 2021-2022 | |
| Ekos Corporation | $36.53 | 2019 | |
| Amgen INC. | $34.78 | 2019-2022 | |
| Inspire Medical Systems, INC. | $34.76 | 2025 | Inspire |
| Scpharmaceuticals INC. | $32.92 | 2023-2025 | |
| Vesper Medical | $29.50 | 2021 | |
| Mallinckrodt Hospital Products INC. | $29.32 | 2022 | |
| Cvrx, INC. | $27.70 | 2024 | Barostim Neo System |
| Akcea Therapeutics, INC. | $27.07 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $23.32 | 2025 | Evkeeza |
| Tactile Systems Technology INC | $22.42 | 2023 | Flexitouch Plus, Entre Plus |
| Celonova Biosciences, INC. | $22.34 | 2019 | |
| Edwards Lifesciences Corporation | $21.37 | 2019 | |
| Venclose INC. | $18.34 | 2020 | |
| Gilead Sciences, INC. | $18.28 | 2019 | |
| Lilly USA, LLC | $16.70 | 2025 | Zepbound |
| Mannkind Corporation | $15.83 | 2025 | |
| Kestra Medical Technology Services, INC. | $15.81 | 2025 | Assure Wcd |
| Argon Medical Devices, INC. | $15.66 | 2024 | Clot Management |
| Stryker Corporation | $15.48 | 2025 | Artix Mt |
| Sanofi-Aventis U.S. LLC | $14.67 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $14.21 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $12.40 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$151,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.